<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d481" origId="Losartan"><sentence id="DrugDDI.d481.s0" origId="s0" text="No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital."><entity charOffset="98-117" id="DrugDDI.d481.s0.e0" origId="s0.p6" text="hydrochlorothiazide" type="drug"/><entity charOffset="119-126" id="DrugDDI.d481.s0.e1" origId="s0.p7" text="digoxin" type="drug"/><entity charOffset="128-136" id="DrugDDI.d481.s0.e2" origId="s0.p8" text="warfarin" type="drug"/><entity charOffset="138-148" id="DrugDDI.d481.s0.e3" origId="s0.p9" text="cimetidine" type="drug"/><entity charOffset="153-166" id="DrugDDI.d481.s0.e4" origId="s0.p11" text="phenobarbital" type="drug"/><pair e1="DrugDDI.d481.s0.e0" e2="DrugDDI.d481.s0.e1" id="DrugDDI.d481.s0.p0" interaction="false"/><pair e1="DrugDDI.d481.s0.e0" e2="DrugDDI.d481.s0.e2" id="DrugDDI.d481.s0.p1" interaction="false"/><pair e1="DrugDDI.d481.s0.e0" e2="DrugDDI.d481.s0.e3" id="DrugDDI.d481.s0.p2" interaction="false"/><pair e1="DrugDDI.d481.s0.e0" e2="DrugDDI.d481.s0.e4" id="DrugDDI.d481.s0.p3" interaction="false"/><pair e1="DrugDDI.d481.s0.e1" e2="DrugDDI.d481.s0.e2" id="DrugDDI.d481.s0.p4" interaction="false"/><pair e1="DrugDDI.d481.s0.e1" e2="DrugDDI.d481.s0.e3" id="DrugDDI.d481.s0.p5" interaction="false"/><pair e1="DrugDDI.d481.s0.e1" e2="DrugDDI.d481.s0.e4" id="DrugDDI.d481.s0.p6" interaction="false"/><pair e1="DrugDDI.d481.s0.e2" e2="DrugDDI.d481.s0.e3" id="DrugDDI.d481.s0.p7" interaction="false"/><pair e1="DrugDDI.d481.s0.e2" e2="DrugDDI.d481.s0.e4" id="DrugDDI.d481.s0.p8" interaction="false"/><pair e1="DrugDDI.d481.s0.e3" e2="DrugDDI.d481.s0.e4" id="DrugDDI.d481.s0.p9" interaction="false"/><negationtags>&lt;xcope&gt;&lt;cue&gt;No&lt;/cue&gt; significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide&lt;/xcope&gt;, digoxin, warfarin, cimetidine and phenobarbital.</negationtags></sentence><sentence id="DrugDDI.d481.s1" origId="s1" text="Rifampin, an inducer of drug metabolism, decreased the concentrations of losartan and its active metabolite."><entity charOffset="0-8" id="DrugDDI.d481.s1.e0" origId="s1.p12" text="Rifampin" type="drug"/><entity charOffset="73-81" id="DrugDDI.d481.s1.e1" origId="s1.p17" text="losartan" type="drug"/><entity charOffset="90-107" id="DrugDDI.d481.s1.e2" origId="s1.p19" text="active metabolite" type="drug"/><pair e1="DrugDDI.d481.s1.e0" e2="DrugDDI.d481.s1.e1" id="DrugDDI.d481.s1.p0" interaction="true"/><pair e1="DrugDDI.d481.s1.e0" e2="DrugDDI.d481.s1.e2" id="DrugDDI.d481.s1.p1" interaction="false"/><pair e1="DrugDDI.d481.s1.e1" e2="DrugDDI.d481.s1.e2" id="DrugDDI.d481.s1.p2" interaction="false"/></sentence><sentence id="DrugDDI.d481.s2" origId="s2" text="In humans, two inhibitors of P450 3A4 have been studied."><entity charOffset="29-37" id="DrugDDI.d481.s2.e0" origId="s2.p22" text="P450 3A4" type="drug"/></sentence><sentence id="DrugDDI.d481.s3" origId="s3" text="Ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan, and erythromycin had no clinically significant effect after oral administration."><entity charOffset="0-12" id="DrugDDI.d481.s3.e0" origId="s3.p26" text="Ketoconazole" type="drug"/><entity charOffset="46-54" id="DrugDDI.d481.s3.e1" origId="s3.p31" text="losartan" type="drug"/><entity charOffset="62-79" id="DrugDDI.d481.s3.e2" origId="s3.p32" text="active metabolite" type="drug"/><entity charOffset="116-124" id="DrugDDI.d481.s3.e3" origId="s3.p34" text="losartan" type="drug"/><entity charOffset="130-142" id="DrugDDI.d481.s3.e4" origId="s3.p36" text="erythromycin" type="drug"/><pair e1="DrugDDI.d481.s3.e0" e2="DrugDDI.d481.s3.e1" id="DrugDDI.d481.s3.p0" interaction="false"/><pair e1="DrugDDI.d481.s3.e0" e2="DrugDDI.d481.s3.e2" id="DrugDDI.d481.s3.p1" interaction="false"/><pair e1="DrugDDI.d481.s3.e0" e2="DrugDDI.d481.s3.e3" id="DrugDDI.d481.s3.p2" interaction="false"/><pair e1="DrugDDI.d481.s3.e0" e2="DrugDDI.d481.s3.e4" id="DrugDDI.d481.s3.p3" interaction="false"/><pair e1="DrugDDI.d481.s3.e1" e2="DrugDDI.d481.s3.e2" id="DrugDDI.d481.s3.p4" interaction="false"/><pair e1="DrugDDI.d481.s3.e1" e2="DrugDDI.d481.s3.e3" id="DrugDDI.d481.s3.p5" interaction="false"/><pair e1="DrugDDI.d481.s3.e1" e2="DrugDDI.d481.s3.e4" id="DrugDDI.d481.s3.p6" interaction="false"/><pair e1="DrugDDI.d481.s3.e2" e2="DrugDDI.d481.s3.e3" id="DrugDDI.d481.s3.p7" interaction="false"/><pair e1="DrugDDI.d481.s3.e2" e2="DrugDDI.d481.s3.e4" id="DrugDDI.d481.s3.p8" interaction="false"/><pair e1="DrugDDI.d481.s3.e3" e2="DrugDDI.d481.s3.e4" id="DrugDDI.d481.s3.p9" interaction="false"/><negationtags>Ketoconazole did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; affect the conversion of losartan to the active metabolite after intravenous administration of losartan&lt;/xcope&gt;, and erythromycin had &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; clinically significant effect after oral administration&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d481.s4" origId="s4" text="Fluconazole, an inhibitor of P450 2C9, decreased active metabolite concentration and increased losartan concentration."><entity charOffset="0-11" id="DrugDDI.d481.s4.e0" origId="s4.p40" text="Fluconazole" type="drug"/><entity charOffset="29-33" id="DrugDDI.d481.s4.e1" origId="s4.p42" text="P450" type="drug"/><entity charOffset="49-66" id="DrugDDI.d481.s4.e2" origId="s4.p44" text="active metabolite" type="drug"/><entity charOffset="95-103" id="DrugDDI.d481.s4.e3" origId="s4.p46" text="losartan" type="drug"/><pair e1="DrugDDI.d481.s4.e0" e2="DrugDDI.d481.s4.e1" id="DrugDDI.d481.s4.p0" interaction="false"/><pair e1="DrugDDI.d481.s4.e0" e2="DrugDDI.d481.s4.e2" id="DrugDDI.d481.s4.p1" interaction="true"/><pair e1="DrugDDI.d481.s4.e0" e2="DrugDDI.d481.s4.e3" id="DrugDDI.d481.s4.p2" interaction="false"/><pair e1="DrugDDI.d481.s4.e1" e2="DrugDDI.d481.s4.e2" id="DrugDDI.d481.s4.p3" interaction="false"/><pair e1="DrugDDI.d481.s4.e1" e2="DrugDDI.d481.s4.e3" id="DrugDDI.d481.s4.p4" interaction="false"/><pair e1="DrugDDI.d481.s4.e2" e2="DrugDDI.d481.s4.e3" id="DrugDDI.d481.s4.p5" interaction="false"/></sentence><sentence id="DrugDDI.d481.s5" origId="s5" text="The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have not been examined."><entity charOffset="55-63" id="DrugDDI.d481.s5.e0" origId="s5.p49" text="losartan" type="drug"/><entity charOffset="82-86" id="DrugDDI.d481.s5.e1" origId="s5.p52" text="P450" type="drug"/><pair e1="DrugDDI.d481.s5.e0" e2="DrugDDI.d481.s5.e1" id="DrugDDI.d481.s5.p0" interaction="false"/><negationtags>&lt;xcope&gt;The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have &lt;cue&gt;not&lt;/cue&gt; been examined&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d481.s6" origId="s6" text="Subjects who do not metabolize losartan to active metabolite have been shown to have a specific, rare defect in cytochrome P450 2C9."><entity charOffset="31-39" id="DrugDDI.d481.s6.e0" origId="s6.p62" text="losartan" type="drug"/><entity charOffset="43-60" id="DrugDDI.d481.s6.e1" origId="s6.p63" text="active metabolite" type="drug"/><entity charOffset="112-131" id="DrugDDI.d481.s6.e2" origId="s6.p70" text="cytochrome P450 2C9" type="drug"/><pair e1="DrugDDI.d481.s6.e0" e2="DrugDDI.d481.s6.e1" id="DrugDDI.d481.s6.p0" interaction="false"/><pair e1="DrugDDI.d481.s6.e0" e2="DrugDDI.d481.s6.e2" id="DrugDDI.d481.s6.p1" interaction="false"/><pair e1="DrugDDI.d481.s6.e1" e2="DrugDDI.d481.s6.e2" id="DrugDDI.d481.s6.p2" interaction="false"/><negationtags>Subjects who do &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; metabolize losartan to active metabolite have been shown to have a specific&lt;/xcope&gt;, rare defect in cytochrome P450 2C9.</negationtags></sentence><sentence id="DrugDDI.d481.s7" origId="s7" text="These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and not P450 3A4."><entity charOffset="42-50" id="DrugDDI.d481.s7.e0" origId="s7.p74" text="losartan" type="drug"/><entity charOffset="58-75" id="DrugDDI.d481.s7.e1" origId="s7.p75" text="active metabolite" type="drug"/><entity charOffset="101-105" id="DrugDDI.d481.s7.e2" origId="s7.p79" text="P450" type="drug"/><entity charOffset="118-126" id="DrugDDI.d481.s7.e3" origId="s7.p81" text="P450 3A4" type="drug"/><pair e1="DrugDDI.d481.s7.e0" e2="DrugDDI.d481.s7.e1" id="DrugDDI.d481.s7.p0" interaction="false"/><pair e1="DrugDDI.d481.s7.e0" e2="DrugDDI.d481.s7.e2" id="DrugDDI.d481.s7.p1" interaction="true"/><pair e1="DrugDDI.d481.s7.e0" e2="DrugDDI.d481.s7.e3" id="DrugDDI.d481.s7.p2" interaction="false"/><pair e1="DrugDDI.d481.s7.e1" e2="DrugDDI.d481.s7.e2" id="DrugDDI.d481.s7.p3" interaction="false"/><pair e1="DrugDDI.d481.s7.e1" e2="DrugDDI.d481.s7.e3" id="DrugDDI.d481.s7.p4" interaction="false"/><pair e1="DrugDDI.d481.s7.e2" e2="DrugDDI.d481.s7.e3" id="DrugDDI.d481.s7.p5" interaction="false"/><negationtags>These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; P450 3A4&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d481.s8" origId="s8" text="As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium."><entity charOffset="14-19" id="DrugDDI.d481.s8.e0" origId="s8.p83" text="drugs" type="drug"/><entity charOffset="31-45" id="DrugDDI.d481.s8.e1" origId="s8.p86" text="angiotensin II" type="drug"/><entity charOffset="81-108" id="DrugDDI.d481.s8.e2" origId="s8.p90" text="potassium-sparing diuretics" type="drug"/><entity charOffset="116-130" id="DrugDDI.d481.s8.e3" origId="s8.p93" text="spironolactone" type="drug"/><entity charOffset="132-143" id="DrugDDI.d481.s8.e4" origId="s8.p94" text="triamterene" type="drug"/><entity charOffset="145-154" id="DrugDDI.d481.s8.e5" origId="s8.p95" text="amiloride" type="drug"/><entity charOffset="157-177" id="DrugDDI.d481.s8.e6" origId="s8.p98" text="potassium supplement" type="drug"/><entity charOffset="183-187" id="DrugDDI.d481.s8.e7" origId="s8.p100" text="salt" type="drug"/><entity charOffset="211-220" id="DrugDDI.d481.s8.e8" origId="s8.p102" text="potassium" type="drug"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e1" id="DrugDDI.d481.s8.p0" interaction="false"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e2" id="DrugDDI.d481.s8.p1" interaction="false"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e3" id="DrugDDI.d481.s8.p2" interaction="false"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e4" id="DrugDDI.d481.s8.p3" interaction="false"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e5" id="DrugDDI.d481.s8.p4" interaction="false"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e6" id="DrugDDI.d481.s8.p5" interaction="false"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e7" id="DrugDDI.d481.s8.p6" interaction="false"/><pair e1="DrugDDI.d481.s8.e0" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p7" interaction="false"/><pair e1="DrugDDI.d481.s8.e1" e2="DrugDDI.d481.s8.e2" id="DrugDDI.d481.s8.p8" interaction="false"/><pair e1="DrugDDI.d481.s8.e1" e2="DrugDDI.d481.s8.e3" id="DrugDDI.d481.s8.p9" interaction="false"/><pair e1="DrugDDI.d481.s8.e1" e2="DrugDDI.d481.s8.e4" id="DrugDDI.d481.s8.p10" interaction="false"/><pair e1="DrugDDI.d481.s8.e1" e2="DrugDDI.d481.s8.e5" id="DrugDDI.d481.s8.p11" interaction="false"/><pair e1="DrugDDI.d481.s8.e1" e2="DrugDDI.d481.s8.e6" id="DrugDDI.d481.s8.p12" interaction="false"/><pair e1="DrugDDI.d481.s8.e1" e2="DrugDDI.d481.s8.e7" id="DrugDDI.d481.s8.p13" interaction="false"/><pair e1="DrugDDI.d481.s8.e1" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p14" interaction="false"/><pair e1="DrugDDI.d481.s8.e2" e2="DrugDDI.d481.s8.e3" id="DrugDDI.d481.s8.p15" interaction="false"/><pair e1="DrugDDI.d481.s8.e2" e2="DrugDDI.d481.s8.e4" id="DrugDDI.d481.s8.p16" interaction="false"/><pair e1="DrugDDI.d481.s8.e2" e2="DrugDDI.d481.s8.e5" id="DrugDDI.d481.s8.p17" interaction="false"/><pair e1="DrugDDI.d481.s8.e2" e2="DrugDDI.d481.s8.e6" id="DrugDDI.d481.s8.p18" interaction="true"/><pair e1="DrugDDI.d481.s8.e2" e2="DrugDDI.d481.s8.e7" id="DrugDDI.d481.s8.p19" interaction="false"/><pair e1="DrugDDI.d481.s8.e2" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p20" interaction="false"/><pair e1="DrugDDI.d481.s8.e3" e2="DrugDDI.d481.s8.e4" id="DrugDDI.d481.s8.p21" interaction="false"/><pair e1="DrugDDI.d481.s8.e3" e2="DrugDDI.d481.s8.e5" id="DrugDDI.d481.s8.p22" interaction="false"/><pair e1="DrugDDI.d481.s8.e3" e2="DrugDDI.d481.s8.e6" id="DrugDDI.d481.s8.p23" interaction="false"/><pair e1="DrugDDI.d481.s8.e3" e2="DrugDDI.d481.s8.e7" id="DrugDDI.d481.s8.p24" interaction="true"/><pair e1="DrugDDI.d481.s8.e3" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p25" interaction="false"/><pair e1="DrugDDI.d481.s8.e4" e2="DrugDDI.d481.s8.e5" id="DrugDDI.d481.s8.p26" interaction="false"/><pair e1="DrugDDI.d481.s8.e4" e2="DrugDDI.d481.s8.e6" id="DrugDDI.d481.s8.p27" interaction="true"/><pair e1="DrugDDI.d481.s8.e4" e2="DrugDDI.d481.s8.e7" id="DrugDDI.d481.s8.p28" interaction="false"/><pair e1="DrugDDI.d481.s8.e4" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p29" interaction="false"/><pair e1="DrugDDI.d481.s8.e5" e2="DrugDDI.d481.s8.e6" id="DrugDDI.d481.s8.p30" interaction="false"/><pair e1="DrugDDI.d481.s8.e5" e2="DrugDDI.d481.s8.e7" id="DrugDDI.d481.s8.p31" interaction="true"/><pair e1="DrugDDI.d481.s8.e5" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p32" interaction="false"/><pair e1="DrugDDI.d481.s8.e6" e2="DrugDDI.d481.s8.e7" id="DrugDDI.d481.s8.p33" interaction="false"/><pair e1="DrugDDI.d481.s8.e6" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p34" interaction="false"/><pair e1="DrugDDI.d481.s8.e7" e2="DrugDDI.d481.s8.e8" id="DrugDDI.d481.s8.p35" interaction="false"/></sentence><sentence id="DrugDDI.d481.s9" origId="s9" text="As with other antihypertensive agents, the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin"><entity charOffset="14-37" id="DrugDDI.d481.s9.e0" origId="s9.p108" text="antihypertensive agents" type="drug"/><entity charOffset="43-59" id="DrugDDI.d481.s9.e1" origId="s9.p109" text="antihypertensive" type="drug"/><entity charOffset="70-78" id="DrugDDI.d481.s9.e2" origId="s9.p110" text="losartan" type="drug"/><entity charOffset="101-137" id="DrugDDI.d481.s9.e3" origId="s9.p114" text="non-steroidal anti-inflammatory drug" type="drug"/><pair e1="DrugDDI.d481.s9.e0" e2="DrugDDI.d481.s9.e1" id="DrugDDI.d481.s9.p0" interaction="false"/><pair e1="DrugDDI.d481.s9.e0" e2="DrugDDI.d481.s9.e2" id="DrugDDI.d481.s9.p1" interaction="false"/><pair e1="DrugDDI.d481.s9.e0" e2="DrugDDI.d481.s9.e3" id="DrugDDI.d481.s9.p2" interaction="false"/><pair e1="DrugDDI.d481.s9.e1" e2="DrugDDI.d481.s9.e2" id="DrugDDI.d481.s9.p3" interaction="false"/><pair e1="DrugDDI.d481.s9.e1" e2="DrugDDI.d481.s9.e3" id="DrugDDI.d481.s9.p4" interaction="false"/><pair e1="DrugDDI.d481.s9.e2" e2="DrugDDI.d481.s9.e3" id="DrugDDI.d481.s9.p5" interaction="true"/></sentence><sentence id="DrugDDI.d481.s10" origId="s10" text="."/><sentence id="DrugDDI.d481.s11" origId="s11" text="?"/></document>